Folgen
Michael Ohene-Nyako
Michael Ohene-Nyako
VCU Medical Center, Dept. Pharmacology and Toxicology
Bestätigte E-Mail-Adresse bei vcuhealth.org
Titel
Zitiert von
Zitiert von
Jahr
Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats
AL Persons, BD Bradaric, HB Dodiya, M Ohene-Nyako, CB Forsyth, ...
PLoS One 13 (1), e0190078, 2018
262018
Morphine and HIV-1 Tat interact to cause region-specific hyperphosphorylation of tau in transgenic mice
M Ohene-Nyako, SR Nass, YK Hahn, PE Knapp, KF Hauser
Neuroscience letters, 2020
152020
Hippocampal blood–brain barrier of methamphetamine self‐administering HIV‐1 transgenic rats
M Ohene‐Nyako, AL Persons, TC Napier
European Journal of Neuroscience 53 (2), 416-429, 2021
102021
Region-specific changes in markers of neuroplasticity revealed in HIV-1 transgenic rats by low-dose methamphetamine
M Ohene-Nyako, AL Persons, TC Napier
Brain Structure and Function 223, 3503-3513, 2018
102018
Neurodegeneration within the amygdala is differentially induced by opioid and HIV-1 Tat exposure
SR Nass, M Ohene-Nyako, YK Hahn, PE Knapp, KF Hauser
Frontiers in Neuroscience 16, 804774, 2022
82022
Independent actions by HIV-1 Tat and morphine to increase recruitment of monocyte-derived macrophages into the brain in a region-specific manner
CR Leibrand, JJ Paris, AM Jones, M Ohene-Nyako, KM Rademeyer, ...
Neuroscience letters 788, 136852, 2022
72022
Accelerated brain aging with opioid misuse and HIV: New insights on the role of glially derived pro-inflammation mediators and neuronal chloride homeostasis
KF Hauser, M Ohene-Nyako, PE Knapp
Current opinion in neurobiology 78, 102653, 2023
62023
Depressive-like behavior is accompanied by prefrontal cortical innate immune fatigue and dendritic spine losses after HIV-1 Tat and morphine exposure
SR Nass, YK Hahn, M Ohene-Nyako, VD McLane, MI Damaj, LR Thacker, ...
Viruses 15 (3), 590, 2023
32023
Casein Kinase 2 Mediates HIV- and Opioid-Induced Pathologic Phosphorylation of TAR DNA Binding Protein 43 in the Basal Ganglia
M Ohene-Nyako, SR Nass, HT Richard, R Lukande, MR Nicol, MP McRae, ...
ASN Neuro 15 (doi:10.1177/17590914231158218), 2023
22023
Progressive Degeneration and Adaptive Excitability in Dopamine D1 and D2 receptor-expressing striatal neurons exposed to HIV-1 Tat and morphine
ARS Lark, LK Silva, SR Nass, MG Marone, M Ohene-Nyako, TM Ihrig, ...
Cellular and Molecular Neurobiology 43 (3), 1105-1127, 2023
12023
Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice
KM Rademeyer, S R. Nass, AM Jones, M Ohene-Nyako, KF Hauser, ...
Journal of NeuroVirology, 1-21, 2024
2024
The blood-brain barrier is dysregulated in the hippocampus of meth self-administering HIV-1 transgenic rats
M Ohene-Nyako, AL Persons, TC Napier
JOURNAL OF NEUROIMMUNE PHARMACOLOGY 14 (2), 346-346, 2019
2019
Evaluation of MMP-9 and ERK in colon barrier dysfunction in meth self-administering HIV-1 transgenic
M Ohene-Nyako, AL Persons, TC Napier
JOURNAL OF NEUROIMMUNE PHARMACOLOGY 13, S62-S62, 2018
2018
Self-administered methamphetamine by HIV-1 transgenic rats alters markers of neuronal activity and plasticity in the limbic brain
M Ohene-Nyako, A Persons, TC Napier
JOURNAL OF NEUROIMMUNE PHARMACOLOGY 12 ((suppl 1)), 3-77, 2017
2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–14